Saniona

Johnny Stilou has a proven track record in corporate finance, capital markets and financial strategy, having served as CFO of Nuevolution (acquired by Amgen Inc.) and Scandion Oncology, as well as EVP & CFO of Veloxis Pharmaceuticals. His experience spans both growth-stage biotech companies and large-cap organizations, making him well suited to support Saniona’s continued development and long-term financing strategy. At Saniona, he will be responsible for the company’s financial strategy, investor relations and funding efforts as the company advances its pipeline toward key value inflection points.

“We are very pleased to welcome Johnny to Saniona,” said Thomas Feldthus, CEO of Saniona. “His deep financial expertise and experience from both sides of M&A and capital markets will be instrumental as we advance our internal pipeline and broaden our investor base.”

Johnny Stilou holds a Cand.Merc.Aud. (MSc in Business Economics and Auditing) and has completed the Executive Management Program at INSEAD. He will be part of Saniona’s executive leadership team and report to the CEO.

“I would like to thank Anita Milland for her dedication and contributions as interim CFO and CFO over the past five years. She has done an outstanding job and will now return to her role as Vice President of Finance & Administration,” said Thomas Feldthus.